• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于局部使用环丙沙星与生理盐水溶液治疗耳漏的双盲前瞻性试验。

A double blind, prospective trial of topical ciprofloxacin versus normal saline solution in the treatment of otorrhoea.

作者信息

Kasemsuwan L, Clongsuesuek P

机构信息

Otolaryngology Department, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Clin Otolaryngol Allied Sci. 1997 Feb;22(1):44-6. doi: 10.1046/j.1365-2273.1997.00857.x.

DOI:10.1046/j.1365-2273.1997.00857.x
PMID:9088679
Abstract

The clinical and bacteriological efficacy of topical ciprofloxacin in saline solution and a saline solution without antibiotics, for the treatment of otorrhoea, was assessed. Fifty affected ears which had an acute exacerbation of chronic otitis media with tympanic membrane perforation were included in this study. Only 35 ears completed the study. Both medications were randomly given to patients. Therapeutic efficacy was evaluated on the seventh day of treatment. A favourable clinical response was observed in 89.5% of the ciprofloxacin-treated group and in 43.8% of the saline-treated group, respectively (P < 0.005). Bacteriological eradication was also observed to be higher in the ciprofloxacin-treated group (P < 0.005). From these preliminary results, topical ciprofloxacin appears to be effective in curing the acute phase of chronic otitis media.

摘要

评估了局部应用环丙沙星生理盐水溶液和不含抗生素的生理盐水溶液治疗耳漏的临床和细菌学疗效。本研究纳入了50只患有慢性中耳炎急性加重伴鼓膜穿孔的患耳。只有35只耳朵完成了研究。两种药物均随机给予患者。在治疗的第七天评估治疗效果。环丙沙星治疗组和生理盐水治疗组分别有89.5%和43.8%观察到良好的临床反应(P<0.005)。环丙沙星治疗组的细菌学根除率也更高(P<0.005)。从这些初步结果来看,局部应用环丙沙星似乎对治愈慢性中耳炎急性期有效。

相似文献

1
A double blind, prospective trial of topical ciprofloxacin versus normal saline solution in the treatment of otorrhoea.一项关于局部使用环丙沙星与生理盐水溶液治疗耳漏的双盲前瞻性试验。
Clin Otolaryngol Allied Sci. 1997 Feb;22(1):44-6. doi: 10.1046/j.1365-2273.1997.00857.x.
2
Topical ciprofloxacin is superior to topical saline and systemic antibiotics in the treatment of tympanostomy tube otorrhea in children: the results of a randomized clinical trial.局部应用环丙沙星优于局部生理盐水和全身应用抗生素治疗儿童鼓膜置管后耳漏:一项随机临床试验的结果。
Laryngoscope. 2010 Dec;120(12):2516-20. doi: 10.1002/lary.21015.
3
Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes.对于患有急性中耳炎且通过鼓膜造孔管出现耳漏的儿科患者,局部使用环丙沙星/地塞米松比单独使用环丙沙星更有效。
Laryngoscope. 2003 Dec;113(12):2116-22. doi: 10.1097/00005537-200312000-00011.
4
A randomised controlled trial of active chronic otitis media comparing courses of eardrops versus one-off topical treatments suitable for primary, secondary and tertiary healthcare settings.一项比较耳滴剂疗程与一次性局部治疗的主动慢性中耳炎随机对照试验,适用于初级、二级和三级医疗保健环境。
Clin Otolaryngol. 2012 Aug;37(4):261-70. doi: 10.1111/j.1749-4486.2012.02532.x.
5
Topical ciprofloxacin vs intramuscular gentamicin for chronic otitis media.外用环丙沙星与肌肉注射庆大霉素治疗慢性中耳炎的比较
Arch Otolaryngol Head Neck Surg. 1992 Aug;118(8):842-4. doi: 10.1001/archotol.1992.01880080064014.
6
[Multicenter study comparing the efficacy and tolerance of topical ciprofloxacin (0.3%) versus topical gentamicin (0.3%) in the treatment of simple, non-cholesteatomaous chronic otitis media in the suppurative phase].
An Otorrinolaringol Ibero Am. 1995;22(5):521-33.
7
Chronic otitis media treated topically with ciprofloxacin or tobramycin.用环丙沙星或妥布霉素局部治疗慢性中耳炎。
Arch Otolaryngol Head Neck Surg. 1997 Oct;123(10):1057-60. doi: 10.1001/archotol.1997.01900100031003.
8
[Efficacy of topical ciprofloxacin in the treatment of chronic otorrhea].局部应用环丙沙星治疗慢性耳漏的疗效
Acta Otorrinolaringol Esp. 1995 Jan-Feb;46(1):15-8.
9
A double-blind, randomized, prospective trial of a topical antiseptic versus a topical antibiotic in the treatment of otorrhoea.一项关于局部用抗菌剂与局部用抗生素治疗耳漏的双盲、随机、前瞻性试验。
Clin Otolaryngol Allied Sci. 1990 Feb;15(1):7-10. doi: 10.1111/j.1365-2273.1990.tb00425.x.
10
Ototopical ciprofloxacin in a glycerin vehicle for the treatment of acute external otitis.甘油载体制剂的耳用环丙沙星用于治疗急性外耳道炎。
Ear Nose Throat J. 2004 Sep;83(9):625-6, 628, 630 passim.

引用本文的文献

1
Topical antibiotics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗生素
Cochrane Database Syst Rev. 2025 Jun 9;6:CD013051. doi: 10.1002/14651858.CD013051.pub3.
2
Topical antibiotics with steroids for chronic suppurative otitis media.用于慢性化脓性中耳炎的含类固醇局部用抗生素
Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD013054. doi: 10.1002/14651858.CD013054.pub2.
3
Topical versus systemic antibiotics for chronic suppurative otitis media.局部用抗生素与全身用抗生素治疗慢性化脓性中耳炎的疗效比较。
Cochrane Database Syst Rev. 2021 Feb 9;2(2):CD013053. doi: 10.1002/14651858.CD013053.pub2.
4
Topical antiseptics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗菌剂。
Cochrane Database Syst Rev. 2020 Jan 6;1(1):CD013055. doi: 10.1002/14651858.CD013055.pub2.
5
Antibiotics versus topical antiseptics for chronic suppurative otitis media.抗生素与外用消毒剂治疗慢性化脓性中耳炎的比较
Cochrane Database Syst Rev. 2020 Jan 6;1(1):CD013056. doi: 10.1002/14651858.CD013056.pub2.
6
Topical antibiotics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗生素
Cochrane Database Syst Rev. 2020 Jan 2;1(1):CD013051. doi: 10.1002/14651858.CD013051.pub2.
7
Efficacy and safety of ofloxacin and its combination with dexamethasone in chronic suppurative otitis media. A randomised, double blind, parallel group, comparative study.氧氟沙星及其与地塞米松联合应用于慢性化脓性中耳炎的疗效与安全性。一项随机、双盲、平行组对比研究。
Acta Otorhinolaryngol Ital. 2015 Feb;35(1):39-44.
8
Topical vs Combination Ciprofloxacin in the Management of Discharging Chronic Suppurative Otitis Media.局部用环丙沙星与联合使用环丙沙星治疗慢性化脓性中耳炎流脓的比较
J Clin Diagn Res. 2014 Jun;8(6):KC01-4. doi: 10.7860/JCDR/2014/8038.4421. Epub 2014 Jun 20.
9
Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations.用于伴有鼓膜穿孔的慢性耳流脓且不含类固醇的外用抗生素。
Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD004618. doi: 10.1002/14651858.CD004618.pub2.